Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma
- 21 March 2013
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 34 (3) , 1913-1918
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaBMC Cancer, 2010
- The Akt and ERK Activation by Platinum-based Chemotherapy in Ovarian Cancer is Associated with Favorable Patient Outcome2009
- Targeting AKT with the proapoptotic peptide, TAT‐CTMP: A novel strategy for the treatment of human pancreatic adenocarcinomaInternational Journal of Cancer, 2009
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Updated treatment approach to hepatocellular carcinomaJournal of Gastroenterology, 2005
- Non-Hodgkin lymphoma: an updateThe Lancet Oncology, 2004
- ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt SignalingMolecular and Cellular Biology, 2004
- ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiationOncogene, 2003
- Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM ProteinJournal of Biological Chemistry, 2003
- Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group TrialJournal of Clinical Oncology, 2001